Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: SARS-CoV-2 infection/Vaccine breakthrough infection; SARS-CoV-2 infection/Vaccine breakthrough infection; This is a spontaneous report from a contactable healthcare professional received from the Regulatory Authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202103231247133620, Safety Report Unique Identifier is GB-MHRA-ADR 25005489. An 86-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date were not reported), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient''s medical history and concomitant medications were not reported. It was unsure if patient has had symptoms associated with COVID-19. Patient was not enrolled in clinical trial. On 31Jan2021, the patient experienced SARS-CoV-2 infection/vaccine breakthrough infection. It was reported that the patient received COVID vaccine on 07Jan2021. Tested positive for COVID on 31Jan2021 and was admitted to hospital. Treated with antibiotics and dexamethasone. The reporter assessed the events as serious (hospitalization and death). The patient underwent lab tests and procedures which included chest x-ray: unknown results on an unspecified date and COVID-19 virus test: positive (yes/positive COVID-19 test) on 31Jan2021. The outcome of the events was fatal. The patient died on 08Feb2021 due to SARS-CoV-2 infection/vaccine breakthrough infection. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about batch/lot number cannot be obtained.; Reported Cause(s) of Death: SARS-CoV-2 infection/Vaccine breakthrough infection; SARS-CoV-2 infection/Vaccine breakthrough infection
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166